The Discovery Park Startup Showcase took centre stage at the London Biotechnology Show 2025, sparking dynamic conversations and real-time feedback between emerging biotech entrepreneurs and seasoned investors.
Natco Pharma announced on Thursday that it received a Form 483 from the United States Food and Drug Administration (USFDA) with seven observations following an inspection of its pharmaceutical division in Hyderabad...
With the updated Schedule M guidelines representing significant compliance issues for small and medium pharmaceutical units, the Mysuru pharma industry has taken a joint initiative to try and prepare for it...
Eli Lilly said on Thursday it would appeal against a UK agency's recommendation to not reimburse the cost of Alzheimer's drug Kisunla, blocking access for patients seeking treatment under the country...
.jpeg "Abbott, MSD Partner to Boost Diabetes Drug Distribution Nationwide")
In a significant move that intended to improve access diabetes care in India, global pharmaceutical leaders Abbott and MSD Pharmaceuticals have entered into a strategic partnership
Glenmark Pharmaceuticals announced on Wednesday that the US FDA issued a Form 483 with five procedural observations after an inspection of its Monroe Manufacturing Facility in North Carolina...
As the deadline has now passed, a large number of India’s small and mid-sized pharmaceutical manufacturers may be forced to shut down, as they have failed to provide required upgrade plans...
Welcure Drugs & Pharmaceuticals announced on Wednesday that it has finalized a contract with Thailand-based Fortune Sagar Impex Compamy for third-party sourcing and procurement services totaling Rs 517 cr
.jpeg "Pharmaceutical Exports Climb 7.4% in May, Continuing Upward Trend")
India's drug exports and pharmaceuticals posted a year-on-year increase of 7.4 percent to US dollar 2.47 billion in May 2025 from US dollar 2.31 billion in the corresponding month last year, based on Ministry of Commerce and Industry released data.
Alembic Pharmaceuticals Ltd reported on Wednesday, June 18, that it has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its API-III manufacturing site, at Karakhadi, Gujarat...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")